Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells

Peptides

Volumn 28, Issue 5, 2007, Pages 1059-1067

  Kageyama, Kazunori ^a   Hanada, Komaki ^a   Nigawara, Takeshi ^a   Furukawa, Ken Ichi ^a   Terui, Ken ^a   Ogura, Eriko ^a   Motomura, Shigeru ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Corticotropin releasing factor receptor; Cyclic AMP; Glucocorticoids; Interleukin 6; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; PROTEIN UROCORTIN 1; PROTEIN UROCORTIN 2; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN III;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BLOTTING, WESTERN; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 34247484058     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.02.002     Document Type: Article

References (54)

1. Ando T., Rivier J., Yanaihara H., and Arimura A. Peripheral corticotropin-releasing factor mediates the elevation of plasma IL-6 by immobilization stress in rats. Am J Physiol 275 (1998) R1461-R1467
2. Bamberger C.M., Wald M., Bamberger A.M., Ergun S., Beil F.U., and Schulte H.M. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83 (1998) 708-711
3. Brar B.K., Stephanou A., Knight R., and Latchman D.S. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol 34 (2002) 483-492
4. Brouxhon S.M., Prasad A.V., Joseph S.A., Felten D.L., and Bellinger D.L. Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat. Brain Behav Immun 12 (1998) 107-122
5. Castell J.V., Gomez-Lechon M.J., David M., Andus T., Geiger T., Trullenque R., et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242 (1989) 237-239
6. Chang C.P., Pearse R.I., O'Connell S., and Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11 (1993) 1187-1195
7. Chen R., Lewis K.A., Perrin M.H., and Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci (USA) 90 (1993) 8967-8971
8. Funakoshi Y., Ichiki T., Ito K., and Takeshita A. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34 (1999) 118-125
9. Honjo T., Inoue N., Shiraki R., Kobayashi S., Otsui K., Takahashi M., et al. Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin. J Vasc Res 43 (2006) 131-138
10. Hsu S.Y., and Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7 (2001) 605-611
11. Kageyama K., Bradbury M.J., Zhao L., Blount A.L., and Vale W.W. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140 (1999) 5651-5658
12. Kageyama K., Furukawa K.-I., Miki I., Terui K., Motomura S., and Suda T. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. J Cardiovasc Pharmacol 42 (2003) 561-565
13. Kageyama K., Gaudriault G.E., Bradbury M.J., and Vale W.W. Regulation of corticotropin-releasing factor receptor type 2β messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 141 (2000) 2285-2293
14. Kageyama K., Hanada K., Moriyama T., Imaizumi T., Satoh K., and Suda T. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol Cell Endocrinol 263 (2007) 90-102
15. Kageyama K., Hanada K., Nigawara T., Moriyama T., Terui K., Sakihara S., et al. Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells. Endocrinology 147 (2006) 4454-4462
16. Kageyama K., Li C., and Vale W.W. Corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in rat pituitary: localization and regulation by immune challenge, restraint stress, and glucocorticoids. Endocrinology 144 (2003) 1524-1532
17. Kageyama K., and Suda T. Regulation of corticotropin-releasing factor receptor type 2β messenger ribonucleic acid by Interleukin-1β in the rat vascular smooth muscle cells. Neuroimmunomodulation 9 (2001) 326-332
18. Kageyama K., and Suda T. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5′-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. Endocrinology 144 (2003) 2234-2241
19. Kageyama K., Watanobe H., and Takebe K. In vivo evidence that arginine vasopressin is involved in the adrenocorticotropin response induced by interleukin-6 but not by tumor necrosis factor-alpha in the rat. Neuroimmunomodulation 2 (1995) 137-140
20. Karalis K., Muglia L.J., Bae D., and Hilderbrand J.A. CRH and the immune system. J Neuroimmunol 72 (1997) 131-136
21. Kishimoto T., Pearse II R.V., and Lin C.R. Rosenfeld MG. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci (USA) 92 (1995) 1108-1112
22. Kostich W.A., Chen A., Sperle K., and Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol Endocrinol 12 (1998) 1077-1085
23. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci (USA) 98 (2001) 7570-7575
24. Libermann T.A., and Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10 (1990) 2327-2334
25. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
26. Lovenberg T.W., Chalmers D.T., Liu C., and De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136 (1995) 4139-4142
27. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci (USA) 92 (1995) 836-840
28. Lydyard P., and Grossi C. The lymphoid system. In: Roitt I., Brostoff J., and Male D. (Eds). Immunology. 5th ed. (1998), Mosby, London, UK 31-41
29. Malkoski S.P., and Dorin R.I. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol 13 (1999) 1629-1644
30. Martens C., Bilodeau S., Maira M., Gauthier Y., and Drouin J. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol 19 (2005) 885-897
31. Parkes D.G., Vaughan J., Rivier J., Vale W., and May C.N. Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 272 (1997) H2115-H2122
32. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., et al. Identification of a second CRF receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci (USA) 92 (1995) 2969-2973
33. Rademaker M.T., Cameron V.A., Charles C.J., and Richards A.M. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 112 (2005) 3624-3632
34. Rattazzi M., Puato M., Faggin E., Bertipaglia B., Zambon A., and Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens 21 (2003) 1787-1803
35. Ray A., Tatter S.B., May L.T., and Sehgal P.B. Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci USA 85 (1988) 6701-6705
36. Ray A., Zhang D.H., Siegel M.D., and Ray P. Regulation of interleukin-6 gene expression by steroids. Ann N Y Acad Sci 762 (1995) 79-87
37. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci (USA) 98 (2001) 2843-2848
38. Schimpl A., and Wecker E. Replacement of T-cell function by a T-cell product. Nat New Biol 237 (1972) 15-17
39. Shimizu H., Mitomo K., Watanabe T., Okamoto S., and Yamamoto K. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 10 (1990) 561-568
40. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273 (1996) 1561-1564
41. Stenzel P., Kesterson R., Yeung W., Cone R.D., Rittenberg M.B., and Stenzel-Poore M.P. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endo 9 (1995) 637-645
42. Suda T., Kageyama K., Sakihara S., and Nigawara T. Physiological roles of urocortins, human homologues of fish urotensin 1, and their receptors. Peptides 25 (2004) 1689-1701
43. Takahashi K., Totsune K., Murakami O., and Shibahara S. Urocortins as cardiovascular peptides. Peptides 25 (2004) 1723-1731
44. Takaki A., Huang Q.H., Somogyvari-Vigh A., and Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1 (1994) 335-342
45. Terui K., Higashiyama A., Horiba N., Furukawa K.I., Motomura S., and Suda T. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol 169 (2001) 177-183
46. Turnbull A.V., and Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79 (1999) 1-71
47. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
48. Vale W., Vaughan J., and Perrin M.H. Corticotropin-releasing factor (CRF) family ligands and their receptors. Endocrinologist 7 (1997) 3S-9S
49. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 (1995) 287-292
50. Venihaki M., Dikkes P., Carrigan A., and Karalis K.P. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 108 (2001) 1159-1166
51. Vita N., Laurent P., Lefort S., Chalon P., Lelias J.M., Kaghad M., et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335 (1993) 1-5
52. Watanabe F., Oki Y., Ozawa M., Masuzawa M., Iwabuchi M., Yoshimi T., et al. Urocortin in human placenta and maternal plasma. Peptides 20 (1999) 205-209
53. Wu Y., Zhou H., Xu Y., and Li S. Enhanced expression of urocortin in lung tissues of rats with allergic asthma. Biochem Biophys Res Commun 341 (2006) 532-540
54. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., and Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133 (1993) 2523-2530